Clinical Trial Update: Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating phenotypic precision medicine to optimize immunosuppression dosing in liver and kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant
• Liver Transplant

Snippet

Sponsor: University of Florida | Conditions: Liver Transplant, Kidney Transplant | Phase 2 | Status: COMPLETED | Results posted: 2021-12-10